TrialThe Lancet. Oncology2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Anthony C Nichols et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
208 papers cite itlatest 60 shown
this paperpooled ittrialcites it